The Implementation of a PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) Program in Portugal

Authors

  • Tiago Bouça-Machado General Surgery Department. Centro Hospitalar Universitário de São João. Porto. https://orcid.org/0000-0001-8954-9961
  • Marisa Aral General Surgery Department. Centro Hospitalar Universitário de São João. Porto.
  • Sara Meireles Department of Medical Oncology. Centro Hospitalar Universitário de São João. Porto.
  • Martin Graversen Odense PIPAC Center & Odense Pancreas Center. Department of Surgery. Upper GI and HPB Section. Odense University Hospital.
  • Elisabete Barbosa General Surgery Department. Centro Hospitalar Universitário de São João. Porto.

DOI:

https://doi.org/10.20344/amp.18834

Keywords:

Aerosols/administration & dosage, Antineoplastic Agents/administration & dosage, Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Neoplasms/drug therapy

Abstract

N/a.

Downloads

Download data is not yet available.

References

Sindayigaya R, Dogan C, Demtröder CR, Fischer B, Karam E, Buggisch JR, et al. Clinical outcome for patients managed with low-dose cisplatin and doxorubicin delivered as pressurized intraperitoneal aerosol chemotherapy for unresectable peritoneal metastases of gastric cancer. Ann Surg Oncol. 2022;29:112-23. DOI: https://doi.org/10.1245/s10434-021-10860-y

Jacquet P, Sugarbaker PH. Peritoneal-plasma barrier. Cancer Treat Res. 1996;82:53-63. DOI: https://doi.org/10.1007/978-1-4613-1247-5_4

Solaß W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849-55. DOI: https://doi.org/10.1007/s00464-012-2148-0

Ellebæk SB, Graversen M, Detlefsen S, Lundell L, Fristrup CW, Pfeiffer P, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum. 2020;5:20200109. DOI: https://doi.org/10.1515/pp-2020-0109

Mortensen MB, Glehen O, Horvath P, Hübner M, Hyung-Ho K, Königsrainer A, et al. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura Peritoneum. 2021;6:91. DOI: https://doi.org/10.1515/pp-2021-0108

Downloads

Published

2022-11-04

How to Cite

1.
Bouça-Machado T, Aral M, Meireles S, Graversen M, Barbosa E. The Implementation of a PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) Program in Portugal. Acta Med Port [Internet]. 2022 Nov. 4 [cited 2024 Dec. 26];35(12):927-8. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/18834

Issue

Vol. 35 No. 12 (2022): Dezembro

Section

Letters to the Editor

License

Copyright (c) 2022 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC